ResMed Inc. | Income Statement

Fiscal year is July-June. All values USD Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,555
1,679
1,839
2,067
2,340
Cost of Goods Sold (COGS) incl. D&A
575
671
796
912
1,024
Gross Income
980
1,008
1,043
1,155
1,316
SG&A Expense
575
594
607
698
756
EBIT
405
414
-
457
560
Unusual Expense
6
34
16
31
51
Non Operating Income/Expense
5
36
14
4
24
Interest Expense
6
6
11
28
28
Pretax Income
431
436
440
419
521
Income Tax
86
83
87
76
206
Consolidated Net Income
345
353
352
342
316
Net Income
345
353
352
342
316
Net Income After Extraordinaries
345
353
352
342
316
Net Income Available to Common
345
353
352
342
316
EPS (Basic)
2.39
2.47
2.49
2.40
2.19
Basic Shares Outstanding
141
140
140
141
143
EPS (Diluted)
2.39
2.47
2.49
2.40
2.19
Diluted Shares Outstanding
144
143
142
142
144
EBITDA
479
487
523
569
680
Non-Operating Interest Income
31
26
17
17
16

About ResMed

View Profile
Address
9001 Spectrum Center Boulevard
San Diego California 92123
United States
Employees -
Website http://www.resmed.com
Updated 07/08/2019
ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C.